Warrants for 447,537 shares feature in Adage's amended Tenax Therapeutics (TENX) stake report.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Adage Capital Management, L.P., along with Robert Atchinson and Phillip Gross, filed an amended Schedule 13G/A report indicating a 2.26% beneficial ownership stake in Tenax Therapeutics, Inc. (TENX). As of September 30, 2026, each reporting person holds 857,270 shares, which includes 447,537 common shares issuable upon the exercise of warrants.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.